Abstract:The PGC2 schizophrenia (SCZ) GWAS shows that variation in non-coding regions is responsible for most of the common variation heritability of the disease, suggesting risk variants alter gene expression. Therefore, comparing differences in gene expression between cases and controls may provide a direct approach for studying the etiology of SCZ. We studied transcriptome expression profiles of Cultured Neural progenitor cells derived from Olfactory Neuroepithelium lines (CNON) from 144 SCZ and 111 control individuals using RNA-Seq and identified 53 differentially expressed (DEX) genes (FDR<0.10). Most DEX genes are implicated in Wnt or Notch signaling, or the metabolism of serine/glutamine/asparagine. DEX genes show enrichment for overlap with significant variants from the SCZ GWAS, and for GO terms related to neurodevelopment: cell differentiation, migration, neurogenesis, and synapse assembly. Our findings show the utility of gene expression analysis of neural progenitors for deciphering molecular aberrations associated with, and potentially causing, schizophrenia. Introduction. Schizophrenia (SCZ) is a devastating psychiatric disorder with estimated lifetime prevalence of 0.55% worldwide (1). With heritability of about 81% (2), genetics plays a critical role in the disease’s etiology. Although causes of the disease remain a mystery, many direct and indirect pieces of evidences indicate that aberrations in brain development are major contributors (3–5). Post-mortem studies of the brains of individuals with SCZ provide important information about functional changes associated with the disease, but it is unlikely that the gene expression profiles of fully differentiated cells can identify all the genes responsible for aberrations in neurodevelopment. Even though the genetic mechanisms regulating neurodevelopment are poorly known, it seems reasonable to suggest that regulation of cell migration and the balance between cell division and differentiation of neuronal cells are critical . CC-BY-NC-ND 4.0 International license a certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under The copyright holder for this preprint (which was not this version posted October 26, 2017. ; https://doi.org/10.1101/209197 doi: bioRxiv preprint

Genetic Implication of Prenatal GABAergic and Cholinergic Neuron Development in Susceptibility to Schizophrenia

Single-Nuclei RNA Sequencing of 5 Regions of the Human Prenatal Brain Implicates Developing Neuron Populations in Genetic Risk for Schizophrenia

Transcriptional programs regulating neuronal differentiation are disrupted in DLG2 knockout human embryonic stem cells and enriched for schizophrenia and related disorders risk variants

The genetics of schizophrenia: glutamate not dopamine?

Genes implicated by a methylome-wide schizophrenia study in neonatal blood show differential expression in adult brain samples

Identification of De Novo Mutations in Prenatal Neurodevelopment-Associated Genes in Schizophrenia in Two Han Chinese Patient-Sibling Family-Based Cohorts

Prenatal Exposure to Famine and Brain Morphology in Schizophrenia

Placental genomic risk scores and early neurodevelopmental outcomes

Genetic Diversity in Schizophrenia: Developmental Implications of Ultra-Rare, Protein-Truncating Mutations

Longitudinal Transcriptomic Analysis of Human Cortical Spheroids Identifies Axonal Dysregulation in the Prenatal Brain as a Mediator of Genetic Risk for Schizophrenia

Prenatal Expression Patterns of Genes Associated With Neuropsychiatric Disorders

Convergent Impact of Schizophrenia Risk Genes

Joint-Tissue Integrative Analysis Identified Hundreds of Schizophrenia Risk Genes

The Role of Genes Affected by Human Evolution Marker GNA13 in Schizophrenia.

GABAergic neuron dysregulation in a human neurodevelopmental model for major psychiatric disorders

Synaptic Protein DLG2 Controls Neurogenic Transcriptional Programs Disrupted in Schizophrenia and Related Disorders

Increased Co-Expression of Genes Harboring the Damaging De Novo Mutations in Chinese Schizophrenic Patients During Prenatal Development

Association of aberrant neural synchrony and altered GAD67 expression following exposure to maternal immune activation, a risk factor for schizophrenia

Gene expression in patient-derived neural progenitors provide insights into neurodevelopmental aspects of schizophrenia

Genetic Insights of Schizophrenia via Single Cell RNA-Sequencing Analyses

Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6P22.1